Universal Biosensors Inc Suspended from ASX Quotation
Key points
- Suspension from quotation due to breach of Listing Rule 12.2
- Appointment of voluntary administrators announced on 20 August 2025
- Suspension to continue until UBI is in compliance with Listing Rules
Full summary
The securities of Universal Biosensors Inc. (UBI) have been suspended from quotation on the Australian Securities Exchange (ASX) with immediate effect. This decision was made by the ASX in accordance with Listing Rule 17.3, as the ASX considers that UBI's financial condition is not adequate to warrant the continued quotation of its securities, and therefore UBI is in breach of Listing Rule 12.2. The suspension follows the announcement made on 20 August 2025 regarding the appointment of voluntary administrators to Universal Biosensors Pty Limited, a subsidiary of UBI. The suspension will continue until the ASX is satisfied that UBI is in compliance with the Listing Rules, including Listing Rule 12.2, and that it is otherwise appropriate for UBI's securities to be reinstated to quotation.
Summary generated by a large language model. Please interpret with care.